US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 113.420
  • +0.380+0.34%
Trading Jan 7 15:54 ET
196.72BMarket Cap34.47P/E (TTM)

Abbott Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Abbott Laboratories Q4 2024 Estimates Date

Currency：USDJan 22, 2025

Estimate YoY
Revenue
11.04B
+7.80%
EPS
1.04
+14.46%
Analyst Rating
Strong Buy

Jan 7, 2025

Abbott Laboratories Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.650B--
Jan 22, 20252024/Q4-- / 11.040B--
Oct 16, 20242024/Q310.635B / 10.551B--
Jul 18, 20242024/Q210.377B / 10.369B--
Apr 17, 20242024/Q19.964B / 9.876B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.650B--
Jan 22, 20252024/Q4-- / 11.040B--
Oct 16, 20242024/Q310.635B / 10.551B--
Jul 18, 20242024/Q210.377B / 10.369B--
Apr 17, 20242024/Q19.964B / 9.876B--

Unlock Free Earnings Estimates

Abbott Laboratories Earnings Reports

  • Abbott Laboratories | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 17:16 ET

  • Abbott Laboratories | 8-K: Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range

    Oct 16, 2024 07:42 ET

  • Abbott Laboratories | 10-Q: Q2 2024 Earnings Report

    Jul 31, 2024 16:06 ET

  • Abbott Laboratories | 8-K: Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance

    Jul 18, 2024 07:41 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Strong Buy

    • Buy

      89.47%

    • Hold

      10.53%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+1.37%
    Mpox (monkeypox)
    Mpox (monkeypox)
    Intraday+1.09%